8TYO

Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2

8TYO の概要

• エントリーDOI: 10.2210/pdb8tyo/pdb
• EMDBエントリー: 41727
• 分子名称: Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
• 機能のキーワード: spike, trimer, surface, viral protein
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 418832.42

構造登録者

Bruch, E.M.,Rak, A. (登録日: 2023-08-25, 公開日: 2024-02-07)

• 主引用文献: Bruch, E.M.,Zhu, S.,Szymkowicz, L.,Blake, T.,Kiss, T.,James, D.A.,Rak, A.,Narayan, K.,Balmer, M.T.,Chicz, R.M.; Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2.; Sci Rep, 14:2038-2038, 2024; PubMed: 38263191; DOI: 10.1038/s41598-024-52499-1

実験手法

ELECTRON MICROSCOPY (2.75 Å)